Lupus News

Voclosporin, when added to mycophenolate mofetil and low-dose steroids, results in higher complete renal response rates in patients with lupus nephritis, compared with mycophenolate mofetil and low-dose steroids alone, according to data.

Patients with lupus nephritis who received voclosporin maintained “meaningful” reductions in proteinuria, with stable mean estimated glomerular filtration rates, at 2 years, according to a poster session at the EULAR 2021 Virtual Congress.

Findings from the Live Yes! INSIGHTS survey from the Arthritis Foundation showed that out of some 40,000 patient responses, 100% reported experiencing some kind of pain within the last 7 days.

Although the seroprevalence of SARS-CoV-2 in patients with immune-mediated inflammatory diseases is comparable to the general population, increased systemic inflammation among these patients is linked to symptomatic COVID-19, according to researchers.

Studies that feature work participation as an outcome in patients with inflammatory arthritis should identify key contextual factors — such as job type or social security system — upfront, according to new “points to consider” from EULAR.

The FDA has issued a warning letter to an online pharmacy for allegedly selling unapproved and misbranded drugs, including hydroxychloroquine and chloroquine, for the treatment of COVID-19, lupus, rheumatoid arthritis and other diseases.

There is no association between a child’s ethnicity and the risk for neonatal lupus erythematosus, nor for any specific disease symptoms, according to data published in The Journal of Rheumatology.

After decades of research advances and reverses, blocking the interferon receptor in lupus may finally be showing consistent clinical benefit, according to a presentation at the United Rheumatology Spring Virtual conference.

Experimental studies indicate that sleep loss can lead to elevated concentrations of proinflammatory cytokines and enhance the perception of pain among patients with immune-mediated inflammatory diseases, according to a speaker here.

Given the link between puberty and autoimmune rheumatic disease, a group of researchers has recommended that clinical assessments of young patients with such conditions record pubertal issues at every encounter.